Search results
Earnings call: Daiichi Sankyo posts strong FY 2023 results, plans growth By Investing.com
Investing.com· 4 hours agoThe pharmaceutical company's strong performance was primarily driven by robust sales of its key...
Moderna (MRNA) Gears Up for Q1 Earnings: Here's What to Expect
Zacks· 22 hours agoInvestors' focus will likely be on updates on Moderna's (MRNA) expected RSV vaccine launch and its late-stage pipeline candidates when it reports first-quarter earnings.
Doing What’s Right
KGTV San Diego· 4 days agoKeep track of the way people are spending your tax dollars and treating your community.
McKee eyes repurposing unspent federal health relief for Washington Bridge, other projects
Providence Business News· 12 hours agoAs the daily news headlines detailing the spread of bird flu grow, so does Dr. Leonard Mermel’s...
A Better Concept For mRNA Vaccines: Self-Amplification
Forbes· 22 hours agoTwo new self-amplifying mRNA vaccines herald a new era of vaccination for coronaviruses.
Wall Street plunges after US inflation shock
The Telegraph via Yahoo Finance· 4 days agoUS stock markets plunged amid fears of stagflation in the American economy, which grew at its slowest pace in nearly two years just as inflation jumped.
Europe Strengthens Future Disease Defense
Medscape· 4 days agoA network of health security agencies has been established in Europe and Central Asia to bolster the region's preparedness to meet future disease...
3 Dividend Stocks to Buy and Hold for the Next Decade
Motley Fool via Yahoo Finance· 3 days agoA rebound in COVID-19 sales and counterbalancing the impending patent cliff isn't enough to make...
Census change will lead to more data on health of Middle Eastern, North African people in US
Michigan Advance via Yahoo News· 4 days agoBefore the successful, healthy birth of her son, recalls Germine Awad — an Egyptian American who is...
3 High-Yield Dividend Stocks That Could Soar 22% to 49%, According to Wall Street
Motley Fool via Yahoo Finance· 2 days ago* Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance...
